These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma. Jia H, Li J, Huang W, Lin G. BMC Med Imaging; 2021 Oct 15; 21(1):149. PubMed ID: 34654379 [Abstract] [Full Text] [Related]
3. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping. Kim M, Jang KM, Kim JH, Jeong WK, Kim SH, Kang TW, Kim YK, Cha DI, Kim K. Eur Radiol; 2017 Apr 15; 27(4):1722-1732. PubMed ID: 27510628 [Abstract] [Full Text] [Related]
4. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation. Schima W, Böhm G, Rösch CS, Klaus A, Függer R, Kopf H. Cancer Imaging; 2020 Jul 23; 20(1):52. PubMed ID: 32703312 [Abstract] [Full Text] [Related]
6. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions. Aslan S, Nural MS, Camlidag I, Danaci M. Abdom Radiol (NY); 2019 Feb 23; 44(2):593-603. PubMed ID: 30225610 [Abstract] [Full Text] [Related]
7. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers. Li J, Lu J, Liang P, Li A, Hu Y, Shen Y, Hu D, Li Z. Cancer Med; 2018 Oct 23; 7(10):4924-4931. PubMed ID: 30151864 [Abstract] [Full Text] [Related]
10. Pancreatitis and PDAC: association and differentiation. Elsherif SB, Virarkar M, Javadi S, Ibarra-Rovira JJ, Tamm EP, Bhosale PR. Abdom Radiol (NY); 2020 May 23; 45(5):1324-1337. PubMed ID: 31705251 [Abstract] [Full Text] [Related]
17. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging. Jang KM, Kim SH, Kim YK, Song KD, Lee SJ, Choi D. Eur J Radiol; 2015 Aug 23; 84(8):1473-1479. PubMed ID: 26032128 [Abstract] [Full Text] [Related]
19. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging. Guo C, Chen X, Wang Z, Xiao W, Wang Q, Sun K, Zhuge X. Oncotarget; 2017 Jun 27; 8(26):42962-42973. PubMed ID: 28487490 [Abstract] [Full Text] [Related]